Company Profile

Axon Dx LLC
Profile last edited on: 3/26/21      CAGE: 7CCH7      UEI: MTLNDGKGVNX7

Business Identifier: Imaging technologies for rare cancer cells
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

379 Reas Ford Road Suite 1
Earlysville, VA 22936
   (540) 239-0668
Location: Single
Congr. District: 05
County: Albemarle

Public Profile

Axon DX LLC develops imaging technologies and products for the identification and research of rare cancer cells such as circulating tumor cells and circulating endothelial cells. The firm's primary platform, nCyte, is a research tool that allows for morphological and targets molecular characterization of Circulating Rare Cells. The platform offers enhanced scanning optical systems powered by AI and utilizes biomarkers for enhanced insight.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 NSF $1,224,128
Project Title: Development of AI Software to Capture and Identify Circulating Rare Cells in Lung Patients

Key People / Management

  Kent Murphy -- CEO

  Yongjian Yu